KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Preferred Dividend Payments (2016 - 2018)

Historic Preferred Dividend Payments for Neogenomics (NEO) over the last 4 years, with Q2 2018 value amounting to $2.8 million.

  • Neogenomics' Preferred Dividend Payments rose 19827.77% to $2.8 million in Q2 2018 from the same period last year, while for Mar 2019 it was $2.8 million, marking a year-over-year decrease of 4993.68%. This contributed to the annual value of $5.6 million for FY2018, which is 4664.83% down from last year.
  • As of Q2 2018, Neogenomics' Preferred Dividend Payments stood at $2.8 million, which was up 19827.77% from $1.0 million recorded in Q1 2018.
  • Neogenomics' Preferred Dividend Payments' 5-year high stood at $8.0 million during Q4 2016, with a 5-year trough of $122000.0 in Q4 2015.
  • For the 4-year period, Neogenomics' Preferred Dividend Payments averaged around $3.1 million, with its median value being $2.7 million (2017).
  • As far as peak fluctuations go, Neogenomics' Preferred Dividend Payments soared by 643524.59% in 2016, and later crashed by 8394.11% in 2017.
  • Over the past 4 years, Neogenomics' Preferred Dividend Payments (Quarter) stood at $122000.0 in 2015, then surged by 6435.25% to $8.0 million in 2016, then plummeted by 66.25% to $2.7 million in 2017, then grew by 2.97% to $2.8 million in 2018.
  • Its Preferred Dividend Payments was $2.8 million in Q2 2018, compared to $1.0 million in Q1 2018 and $2.7 million in Q4 2017.